News

For atypical dementia, temporoparietal cortical thickness beats hippocampal volume


 

AT AAIC 2013

Dr. Rabinovici has received research support from Eli Lilly and has consulted for GE Healthcare and Eli Lilly, both of which produce amyloid imaging agents. Mr. Cohn-Sheehy, who presented the findings during the meeting, is a medical student under Dr. Rabinovici’s supervision.

msullivan@frontlinemedcom.com

On Twitter @Alz_Gal

Pages

Recommended Reading

Glucose, insulin measures unrelated to AD pathology
MDedge Psychiatry
Hospitalized, elderly, and delirious: What should you do for these patients?
MDedge Psychiatry
Aerobic exercise boosts brain power in mild cognitive impairment
MDedge Psychiatry
Making the distinction between dementia and delirium
MDedge Psychiatry
Dihydropyridine calcium channel blockers in dementia and hypertension
MDedge Psychiatry
Higher glucose linked to increased dementia risk
MDedge Psychiatry
New drug matched donepezil’s efficacy in mild to moderate Alzheimer’s
MDedge Psychiatry
Alzheimer’s biomarkers have limited use in diagnosing frontotemporal dementia
MDedge Psychiatry
Labor induction, augmentation may be tied to autism risk
MDedge Psychiatry
Studies speak volumes about brain changes and cognition in women
MDedge Psychiatry